Venetoclax-based therapy in treatment-naive and relapsed/refractory acute myeloid leukemia. Ravindra A, Acharya L, Loeffler B, Mott S, et al. Leuk Res 2023;135:107407.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ravindra A, Acharya L, Loeffler B, Mott S, et al. Venetoclax-based therapy in treatment-naive and relapsed/refractory acute myeloid leukemia. Leuk Res 2023;135:107407.
PMID: 37925761